Individuals Coming Off Weight-Loss Jabs Regain Weight Four Times Faster Than Those on Conventional Diets

A recent study indicates that patients who discontinue popular slimming jabs like semaglutide or tirzepatide may regain lost weight far faster than those who end traditional lifestyle plans.

Published data in a leading medical journal shows that while obese individuals can lose about a fifth of their total mass while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month upon discontinuation.

"People purchasing such treatments must be cognizant of the risk of rapid rebound weight gain when the medication concludes," cautioned expert Dr. Susan Jebb.

This pace of recovery means a reversion to starting weight within about one and a half years.

Comparing Treatments

The research, which examined dozens of trials involving thousands of participants, compared the results of the injectable medications with other pills.

Scientists emphasize that people who lose weight through dieting typically have a more gradual weight regain—approximately 100 grams monthly—once they finish.

Explaining the Fast Regain

Experts propose the mechanism of the injections accounts for the amplified weight return.

These medications copy a natural hormone called GLP-1, which controls feelings of fullness.

"Sustained high doses of the hormone levels far above than the body's typical production may cause the system to produce less of its own natural GLP-1, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.

"Stopping of this hormone supplement means appetite is no longer kept in check, making excessive eating a significant risk."

A Chronic Issue?

The NHS advise the injections for people with obesity-related health risks, accompanied by prescribed lifestyle changes.

Many experts say that, given the high risk of relapse, the treatment might need to be life-long.

This perspective is reinforced by drug manufacturers, who state that the findings "emphasize the chronic nature of obesity," comparing it to managing conditions like high blood pressure.

Patient Testimonies

Users who have discontinued the medication report a powerful return of appetite.

"It felt as if a trigger flipping and you become starving," recalled an individual.

This challenge is compounded if users have not developed permanent dietary or behavioural modifications during treatment.

Widespread Use

Survey data indicate that a significant number of people in the UK have used these injections in the past year, with interest being substantial.

• Adoption is more common among females compared to men.
• The middle-aged demographic shows the highest level of interest.
• A large proportion obtain the drugs through private healthcare rather than the NHS.

In conclusion, experts caution that while these medications are effective tools for shedding pounds, they are not a standalone solution and maintained weight loss hinges on combined lifestyle management.